Revolutionizing Malaria Treatment: The Power of Nano-Engineered Curcumin and Chloroquine
In a groundbreaking study, researchers have developed a nano-formulated drug combining chloroquine and curcumin, aimed at combating malaria more effectively than traditional treatments. This innovative approach leverages nanotechnology to enhance drug delivery and efficacy, particularly against the drug-resistant malaria parasite P. berghei. Early tests in mice show a remarkable 98% reduction in parasite levels at specific dosages, outperforming conventional chloroquine treatments. Importantly, this nano-drug exhibits minimal toxicity, suggesting a safer alternative for patients. These findings pave the way for new malaria therapies, emphasizing the need for further investigation to bring this promising solution to clinical practice.
Article Information
Antimalarial Effects of Nano Chloroquine Loaded Curcumin In vivo
Published in Infectious Disorders Drug Targets. Taher Elmi et al.
Abstract
Background: Malaria is still the deadliest parasitic disease caused by Plasmodium spp. Due to drug resistance and their unpleasant side effects, of conventional researchers are enormously seeking to achieve antimalarial drugs with more curative effective, less toxic and cost-affordable drugs using more advanced technology such as nanodrugs.
Purpose: The present study aimed to examine the antimalarial effects of a novel synthesized nonochloroquine-loaded curcumin relying on dendrimer G2 in susceptible mice.
Methods: Antimalarial activity and toxicity of the nanocomposite were examined on BALB/C mice with microscopy, checking RBCs morphology and related enzymatic activity rate.
Results: The maximum inhibitory effect of the nanocomposite was seen at 10 mg/kg, killing 98% of P. berghei compared to sole chloroquine, whereas ED50 was reported at 5.5 mg/kg. The safety of the synthesized nanocomposite was confirmed with biochemical tests with no detrimental effects on mice. The sustainability and longevity of the nanodrug increased significantly with the NDC-CQ assay compared to the control groups.
Conclusion: The study showed that nonochloroquine-loaded curcumin had a promising inhibitory effect on P. berghei growth in infected mice compared to standard drugs. However, further studies and clinical trials with large samples are recommended to study different aspects of using nanodrug.
Bring preventive care to your clinic
© Longevity Artificial Intelligence. All rights reserved.